TG Therapeutics Inc vs Wheaton Precious Metals Corp — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Wheaton Precious Metals Corp trades at $103.33 (market cap $46.54B). The key difference: Wheaton Precious Metals Corp is far larger — about 5.6× TG Therapeutics Inc's market cap, and Wheaton Precious Metals Corp pays a 0.75% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | WPM | |
|---|---|---|
Market Cap | $8.26B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $59.06 | $165.72 |
52-Week Low | $26.39 | $91.00 |
Enterprise Value | $8.50B | $44.39B |
Dividend Yield | — | 0.75% |
Trailing returns across standard periods
Latest headlines on both assets
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →